Multiply Myeloma in North Carolina: Updates - SPOC

Webinar Information

Webinar Description

The management of multiple myeloma is dynamic with a constantly changing landscape. Samuel M. Rubinstein, MD, MSCI, will cover recently published manuscripts and conference presentations that present practice changing data in the management of multiple myeloma

Learning Objectives

  • Discuss updates in the management of management of newly diagnosed multiple myeloma
  • Define advantages and disadvantages of cellular therapeutics and bispecific antibodies
  • Describe potential rationales for early and late cellular therapeutic

 

Webinar Documents

Handouts

 

Webinar Registration


Take Course

You must have an account and be logged in to register. Please contact us with any questions at unclcn@unc.edu or (919) 445–1000.

 

You may also be interested in

Caring for the Patient with Hematologic Cancers: Leukemia, Lymphoma, and Multiple Myeloma

We will provide an introduction to blood cancers including risk factors, epidemiology, presenting symptoms, general treatment, and caregiver and survivorship issues.
Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC): An Evolving Diagnostic and Therapeutic Paradigm
Joshua F. Zeidner, MD, will discuss the evolving diagnostic algorithm for AML-MRC, prognosis, treatment outcomes, and unmet needs.
Lymphoma Management in North Carolina: Updates for 2023
Natalie Grover, MD, will review some of the recent advances in the treatment of lymphoma, including the incorporation of novel targeted agents in the frontline treatment of diffuse large B cell lymphoma and Hodgkin lymphoma, the use of CAR-T cell therapy in second-line treatment in diffuse large B cell lymphoma, and recently approved drugs by the FDA for lymphoma.
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Course opens: 
10/09/2024
Course expires: 
10/08/2026
Research to Practice Logo 

Cancer Treatment in North Carolina: Research to Practice (formerly Medical and Surgical Oncology) webinars cover the spectrum of anti-cancer therapy, with a focus on recent research developments, both locally and at large, and what’s ready for regular practice. Perspectives from medical oncology, radiation oncology, and surgery will be included.

This series incorporates an understanding of practice dynamics and concerns throughout the state of North Carolina, and the availability of clinical trials and subspecialty expertise to inform care.

These webinars provide FREE continuing education credit.

Photo of Samuel M. Rubinstein, MD, MSCI 

Samuel M. Rubinstein, MD, MSCI

Clinical Assistant Professor of Medicine

UNC Lineberger Comprehensive Cancer Center
UNC School of Medicine
University of North Carolina at Chapel Hill

 

Presenter Disclosure Information

The speaker received research support from EUSA Pharma (ended 10/22), Janssen (ended 12/23), LAVA Therapeutics (5/23), and Sanofi (6/23). These financial relationships have been mitigated.

Accreditation Statements

The following accrediting agencies have approved this course for continuing education credits. Participants should understand that their individual participation and claiming credit must abide by the regulations set forth by their respective accrediting agency. No partial credit will be provided.

1.00 NCPD/CNE
UNC Health is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

1.00 ACPE Pharmacist
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

1.00 ACPE Pharmacy Tech
Accreditation Council for Pharmacy Education
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit can be viewed and printed in CPE Monitor in approximately 2 to 3 weeks.

1.00 CTR
Approved by the National Cancer Registrars Association (NCRA).

1.00 ASRT
Approved by the American Society of Radiologic Technologists (ASRT).
This activity may be available in multiple formats. A self-learning activity can be completed only once per biennium.

 

In most cases, regulations prohibit the repeated use of the same educational activity (Live Webinar or Self-Paced, Online Course but not both) as it relates to satisfying CE requirements to maintain licensure. Attendees are also required to view a minimum of 53 minutes of the live webinar video to receive CE credit. Please contact your individual accreditation agencies for more details.

Altering or submitting modified certificates constitutes fraud that can result in punitive action by the accrediting agency.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 ODS
  • 1.00 NCPD/CNE
  • 1.00 Participation
Please login or register to take this course.